Major US health systems expect to offer Alzheimer's drug Leqembi in a few months

Explainer-Who is eligible for the new FDA-approved Alzheimer's drug?

US FDA panel back traditional approval for Eisai-Biogen's Alzheimer's drug Leqembi

Eisai, Biogen Alzheimer's drug Leqembi would cost US Medicare up to $5 billion a year, study finds